Simvastatin Tablets Recalled for Potential Labeling Error
Aidapak Services is recalling Simvastatin 40 mg tablets because they may have been mislabeled as Metoprolol Tartrate 12.5 mg.
The agency’s classification
FDA (Drugs): Class II
Class II is a situation in which use of or exposure to a violative product may cause temporary or medically reversible adverse health consequences, or where the probability of serious adverse health consequences is remote.
This is the agency’s own classification, taken from its notice. The severity score below is our assessment, not the agency’s. How recall classes work
What this means for you
Our assessment, not the agency’s: severity 2/5 (Moderate).
Minor labeling or packaging issue, or a voluntary precautionary recall. Risk of harm is low but real — follow the manufacturer's instructions.
Our severity reasoning: The recall is classified as FDA Class II, which typically involves a labeling error that could cause temporary or medically reversible health consequences. No injuries or illnesses are reported in the source text.
Plain-English summary
Aidapak Services, LLC is recalling Simvastatin, Tablet, 40 mg (NDC 00093715598) due to a potential labeling error. The recall is initiated because the product may have been mislabeled as Metoprolol Tartrate, Tablet, 12.5 mg (NDC 63304057901).
The affected Simvastatin tablets have the pedigree AD22845_4 and an expiration date of 5/2/2014. The potentially mislabeled Metoprolol Tartrate tablets have the pedigree AD21790_67 and an expiration date of 5/1/2014. The repacked drugs were distributed in Arizona, California, Oregon, and Washington.
Patients and healthcare providers should verify the identity of their medications. If you have received Simvastatin 40 mg tablets that may be mislabeled as Metoprolol Tartrate 12.5 mg, contact your healthcare provider or pharmacist for guidance on how to proceed.
The recalled product
- Product
- SIMVASTATIN, Tablet, 40 mg, Rx only, Distributed by: AidaPak Service, LLC, NDC 00093715598.
- Manufacturer
- Aidapak Services, LLC
- Category
- Drug — Prescription Medication
- Hazard
- Affected units
- 90
Is your product affected?
Check your packaging against the codes below. If any of them match, the product is part of this recall.
Lot numbers (4)
- SIMVASTATIN
- Tablet
- 40 mg has the following codes: Pedigree: AD22845_4
- EXP: 5/2/2014.
Distribution
Part of a larger recall action
This product is one of 265 recalled by Aidapak Services, LLC under a single FDA (Drugs) recall action. The agency files each product separately, so the size of the action is not visible from this page alone.
See all 265 products in this recall →Related recalls
Same manufacturer · Aidapak Services, LLC
See all →- ModerateAidapak Recalls Sennosides Tablets Due to Potential Labeling Errors
FDA (Drugs) · 2014-01-29
- ModerateLevothyroxine Sodium Tablets Recalled for Potential Labeling Mixup
FDA (Drugs) · 2014-01-29
- ModerateAidapak Recalls Mislabeled Pantoprazole Sodium DR Tablets
FDA (Drugs) · 2014-01-29
- ModerateAidapak Recalls Nifedipine ER Tablets Due to Potential Label Mixup
FDA (Drugs) · 2014-01-29
- ModerateAidapak Recalls Nebivolol Tablets Due to Potential Labeling Errors
FDA (Drugs) · 2014-01-29
Same hazard · mis labeling
See all →- SevereWhite Vein Advanced Alkaloids Chewable Tablets Recall for Excess Active Ingredient
FDA (Food) · 2026-10-14
- SevereBetter Bakehouse Recalls Donutful Chocolate Dipped Vanilla Cake Donuts for Undeclared Milk
FDA (Food) · 2026-10-14
- HighFreshPoint Recalls Cranberry Chicken Salad Wedges for Undeclared Egg Allergen
FDA (Food) · 2026-10-14
- HighJ K Patisserie & Bakery LLC Recalls Croissants for Undeclared Egg
FDA (Food) · 2026-10-14
- ModerateHalyard Laparoscopy Comprehensive Pack II Recalled for Latex Content
FDA (Devices) · 2026-10-14
Similar recalls
- ModerateAidapak Recalls Metoprolol Tablets Due to Potential Labeling Errors
FDA (Drugs) · 2014-01-22
- ModerateAidapak Recalls Metoprolol Tartrate Tablets Due to Labeling Mixup
FDA (Drugs) · 2014-01-22
- ModerateAidapak Recalls Simvastatin Tablets Due to Potential Label Mixup
FDA (Drugs) · 2014-01-22
- SevereFDA Recalls Pimozide Tablets Due to Potential Metoprolol Labeling Error
FDA (Drugs) · 2014-01-22
- ModerateAidapak Recalls Metoprolol Tablets Due to Potential Label Mixup
FDA (Drugs) · 2014-01-22
- SevereLetrozole Tablets Recalled for Potential Mislabeling as Metoprolol Tartrate
FDA (Drugs) · 2014-01-22